IFNA2 and COVID-19: We found that 3 of 19 severe, 7 of 42 critical and 1 of 62 mild COVID-19 patients had elevated titers of IgG to IFN-α2 (defined as levels ≧ 0.5 OD 450nm) (Fig. 1a).